Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis
Links shared publicly online about this topic.
- 519total visits
Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis
View full resource at news-medical.net
Tags: Allergies, Eczema, Psoriasis
Most Recently Shared on February 9, 2011 at 3:22 pm By:
Circassia acquires global rights to novel topical therapeutic for psoriasis and atopic dermatitis: Circassia Ltd... http://bit.ly/goag9Q
Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc - Health News - redOrbit
redorbit.com — “OXFORD, England, February 9, 2011 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales. PAP-1 is one of the most potent and sel” View full resource at redorbit.com
Most Recently Shared on February 9, 2011 at 3:22 pm By:
Circassia Acquires Worldwide Rights to Novel Psoriasis and Atopic Dermatitis Treatment From Airmid Inc: OXFORD, ... http://bit.ly/dMsVIp
Advertisement
